Evidence map›Paper›PMID 23585571›Full record

ArticleThe Journal of biological chemistry2013

Water-soluble LYNX1 residues important for interaction with muscle-type and/or neuronal nicotinic receptors.

Ekaterina N Lyukmanova, Mikhail A Shulepko, Svetlana L Buldakova, Igor E Kasheverov, Zakhar O Shenkarev, Roman V Reshetnikov, Sergey Y Filkin, Denis S Kudryavtsev, Lucy O Ojomoko, Elena V Kryukova and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. A novel anxiety-associated SNP identified inFrontiers in behavioral neuroscience · 2024
    Article
  4. Nicotine: From Discovery to Biological Effects.International journal of molecular sciences · 2023
    Review
  5. Review
  6. Orientational Preferences of GPI-Anchored Ly6/uPAR Proteins.International journal of molecular sciences · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Ekaterina N LyukmanovaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya Street, 117997 Moscow, Russia.
Mikhail A Shulepko
Svetlana L Buldakova
Igor E Kasheverov
Zakhar O Shenkarev
Roman V Reshetnikov
Sergey Y Filkin
Denis S Kudryavtsev
Lucy O Ojomoko
Elena V Kryukova
Dmitry A Dolgikh
Mikhail P Kirpichnikov
Piotr D Bregestovski
Victor I Tsetlin
Russian Academy of Sciences · RUInstitute of Bioorganic Chemistry · RULomonosov Moscow State University · RUAix-Marseille Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human LYNX1, belonging to the Ly6/neurotoxin family of three-finger proteins, is membrane-tethered with a glycosylphosphatidylinositol anchor and modulates the activity of nicotinic acetylcholine receptors (nAChR). Recent preparation of LYNX1 as an individual protein in the form of water-soluble domain lacking glycosylphosphatidylinositol anchor (ws-LYNX1; Lyukmanova, E. N., Shenkarev, Z. O., Shulepko, M. A., Mineev, K. S., D'Hoedt, D., Kasheverov, I. E., Filkin, S. Y., Krivolapova, A. P., Janickova, H., Dolezal, V., Dolgikh, D. A., Arseniev, A. S., Bertrand, D., Tsetlin, V. I., and Kirpichnikov, M. P. (2011) NMR structure and action on nicotinic acetylcholine receptors of water-soluble domain of human LYNX1. J. Biol. Chem. 286, 10618-10627) revealed the attachment at the agonist-binding site in the acetylcholine-binding protein (AChBP) and muscle nAChR but outside it, in the neuronal nAChRs. Here, we obtained a series of ws-LYNX1 mutants (T35A, P36A, T37A, R38A, K40A, Y54A, Y57A, K59A) and examined by radioligand analysis or patch clamp technique their interaction with the AChBP, Torpedo californica nAChR and chimeric receptor composed of the α7 nAChR extracellular ligand-binding domain and the transmembrane domain of α1 glycine receptor (α7-GlyR). Against AChBP, there was either no change in activity (T35A, T37A), slight decrease (K40A, K59A), and even enhancement for the rest mutants (most pronounced for P36A and R38A). With both receptors, many mutants lost inhibitory activity, but the increased inhibition was observed for P36A at α7-GlyR. Thus, there are subtype-specific and common ws-LYNX1 residues recognizing distinct targets. Because ws-LYNX1 was inactive against glycine receptor, its "non-classical" binding sites on α7 nAChR should be within the extracellular domain. Micromolar affinities and fast washout rates measured for ws-LYNX1 and its mutants are in contrast to nanomolar affinities and irreversibility of binding for α-bungarotoxin and similar snake α-neurotoxins also targeting α7 nAChR. This distinction may underlie their different actions, i.e. nAChRs modulation versus irreversible inhibition, for these two types of three-finger proteins.

Indexed as

TorpedoAdaptor Proteins, Signal Transducingalpha7 Nicotinic Acetylcholine ReceptorAmino Acid SubstitutionAnimalsBungarotoxinsFish ProteinsGPI-Linked ProteinsHEK293 CellsHumansMutation, MissenseNeurotoxinsReceptors, NicotinicRecombinant Fusion ProteinsAdaptor Proteins, Signal Transducingalpha7 Nicotinic Acetylcholine ReceptorBungarotoxinsChrna7 protein, humanFish ProteinsGPI-Linked ProteinsLYNX1 protein, humanNeurotoxinsReceptors, NicotinicRecombinant Fusion ProteinsAcetylcholine-binding ProteinsComputer ModelingElectrophysiologyIonic CurrentsLYNX1MutagenesisNeurotoxinNicotinic Acetylcholine ReceptorsRadioligand Assay

Identifiers

PMID23585571
PMCPMC3668745
OpenAlexW1968618363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.